openPR Logo
Press release

Global Neuromodulation Devices Market 2016: Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation

09-22-2016 12:48 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Intense Research

Global Neuromodulation Devices Market 2016: Deep Brain

The report analyzes the neuromodulation market based on product type, namely, internal and external neuromodulators. Internal neuromodulators are further segmented into deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, spinal cord stimulation, and other neurostimulators, whereas external neuromodulators are classified into transcutaneous electrical nerve stimulation and repetitive transcranial magnetic stimulation. The market is also segmented based on application, material, and geography.

Complete Report of Neuromodulation Devices Market @ http://www.intenseresearch.com/market-analysis/neuromodulation-devices-market-by-technology-deep-brain-stimulation.html

The report includes the revenue generated from the sales of these aforementioned segments of neuromodulator devices. Spinal cord stimulation is the dominating segment whereas repetitive transcranial magnetic stimulation is the fastest growing segment among various neuromodulation technologies. Chronic pain management is the largest application segment and migraine is the fastest growing segment owing to the high incidence rate.

Get Free Sample Report of Neuromodulation Devices Market @ http://bit.ly/2cPZJh8

The spinal cord stimulation has huge potential to treat widespread chronic back pain. Around 20% of adult Americans experience chronic pain. Recently, USFDA and similar regulatory agencies have approved many products of the SCS technology, for instance Senza SCS System by Nevro Corporation and Proclaim Elite SCS by St. Jude Medical. The use of technology is expanding to new indications such as failed-back surgery syndrome, refractory angina pectoris, peripheral vascular disease, and complex regional pain syndrome.

Deep Brain Stimulation (DBS) market is projected to exhibit significant growth due to high adoption rate in developed economies for neurological disorders, such as Parkinson’s disease, which have no known cure. The use of DBS is expanding to new indications, such as severe obsessive-compulsive disorder, treatment-resistant depression, Alzheimer's type dementia, and movement disorders.

Tremor is one of the major applications of neuromodulation devices. Tremor is a nerve disorder characterized by uncontrollable shaking or tremors in different parts of the body such as hands, arms, head, larynx (voice box), tongue, and chin. Tremor affects several million people above the age of 40 years. It is majorly caused due to genetic mutations. Tremor impairs routine activities, such as eating, drinking, and writing of patients. Number of implantable deep brain stimulators is now available for the management of tremors.

For instance, Medtronic’s deep brain neurostimulators are implanted surgically within the thalamus, which is the brain’s communication center. The lead is connected to an implanted pulse generator by an extension wire running beneath the skin. The electrical stimulation can be noninvasively adjusted to block signals that cause disabling motor symptoms of essential tremor. Increasing prevalence of this disorder, technological improvement in neurostimulator devices, and increasing FDA approvals for neurostimulators are expected to drive the market.

About Intense Research

Intense Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air.

Contact Us

Nicole Austin
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651
Email: nicole@Intenseresearch.com
Web: http://www.intenseresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Neuromodulation Devices Market 2016: Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation here

News-ID: 365879 • Views: 1629

More Releases from Intense Research

Global Orthopaedic Imaging Equipments Market 2019 - GE Healthcare, Stryker, Siem …
The global "Orthopaedic Imaging Equipments Market" report delivers a comprehensive and systematic framework of the Orthopaedic Imaging Equipments market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Orthopaedic Imaging Equipments market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis
Global Enzyme Inhibitor Market 2019 - AstraZeneca, Merck, Novartis, Pfizer, Ranb …
The global "Enzyme Inhibitor Market" report delivers a comprehensive and systematic framework of the Enzyme Inhibitor market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Enzyme Inhibitor market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis and calculations. The
Global Fixed or Mean Value Condylar Path articulators Market 2019 - SAM-Dental H …
The global "Fixed or Mean Value Condylar Path articulators Market" report delivers a comprehensive and systematic framework of the Fixed or Mean Value Condylar Path articulators market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Fixed or Mean Value Condylar Path articulators market and the research team meticulously analyze the gathered data with the
Global Intraocular Lenses Market 2019 - Accu-Lens, Alcon (Novartis), ClarVista,n …
The global "Intraocular Lenses Market" report delivers a comprehensive and systematic framework of the Intraocular Lenses market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Intraocular Lenses market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis and calculations. The

All 5 Releases


More Releases for Neuromodulation

Neuromodulation Market to Reach $11,717 Million, Globally, by 2022
The global neuromodulation market size is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. The global neuromodulation devices market is estimated to reach $11,717 million by 2022. Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections can also cause neurological disorders. To manage such disorders, neuromodulation is used,
Neuromodulation Devices Market Projected to Grow Steadily During 2017 - 2027
Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation.Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a
Neuromodulation Devices Market Analysis and Forecast Study for 2017-2027
Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation.Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a
Global Neuromodulation Devices Market 2027: Comprehensive Report Study
Market Research Future published a research report on “Global Neuromodulation Devices Market Research Report- Forecast To 2027” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027. Global neuromodulation devices market Information, by types by Techniques Applications - Forecast to 2027 Globally the market for neuromodulation devices is increasing rapidly. The major factor that derives the growth of neuromodulation devices is the increasing development neuromodulation devices. Furthermore increasing demand
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum
Internal Neuromodulation Devices Market : Global Markets & Advanced Technologies
Internal neuromodulation devices directly act upon nerves. It is the technology known for alteration of nerve activity directly to a target area by sending electrical or pharmaceutical agents directly to a target area. The neuromodulation devices can treat nearly every disease considering every area of body. The diseases or symptoms from headache to spinal cord damage to tremor and many others. Neuromodulation technology is significantly improving in biotechnology with its